CurrentEndo coverage · page 18 of 33
Cardiovascular Diabetology
Latest from Cardiovascular Diabetology
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Effect of ertugliflozin on left ventricular function in type 2 diabetes and pre-heart failure: the Ertu-GLS randomized clinical trial
Randomized controlled trialT2D & other
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Multi-modal characterisation of early-stage, subclinical cardiac deterioration in patients with type 2 diabetes
Cross-sectional studyComplications
Cardiovasc Diabetol
Altered RBC deformability in diabetes: clinical characteristics and RBC pathophysiology
Cross-sectional studyComplications
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiometabolic benefits of fenofibrate in heart failure related to obesity and diabetes
Mechanistic studyComplications
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Effects of dietary interventions and intermittent fasting on HDL function in obese individuals with T2DM: a randomized controlled trial
Randomized controlled trialT2D & other
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Cardiovasc Diabetol
Mendelian randomization analysis reveals causal effects of blood lipidome on gestational diabetes mellitus
Diagnostic or prognostic studyDiabetes in pregnancy
Cardiovasc Diabetol
Cardiovasc Diabetol